Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose aspirin in non-cardioembolic ischemic stroke and microbleeds
NCT04504864Phase 4Unknown
- Sponsor
- Xijing Hospital
- Start
- Oct 2020
- Primary completion
- Feb 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of aspirin in ischemic stroke, sponsored by Xijing Hospital. Status: unknown.
02
Drugs
aspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04504864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04504864.